HFS
GSK icon

HL Financial Services’s GSK GSK Stock Holding History

HL Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.98M Sell
37,834
-1,010
-3% -$50.5K 0.03% 289
2018
Q4 		$1.85M Buy
38,844
+367
+1% +$18.1K 0.03% 278
2018
Q3 		$1.93M Sell
38,477
-2,005
-5% -$102K 0.03% 291
2018
Q2 		$2.04M Sell
40,482
-1,953
-5% -$98.4K 0.04% 269
2018
Q1 		$2.07M Sell
42,435
-1,321
-3% -$61.5K 0.04% 249
2017
Q4 		$1.94M Sell
43,756
-2,296
-5% -$106K 0.04% 219
2017
Q3 		$2.34M Sell
46,052
-3,552
-7% -$180K 0.05% 227
2017
Q2 		$2.67M Sell
49,604
-1,317
-3% -$70.2K 0.05% 215
2017
Q1 		$2.68M Buy
50,921
+5,087
+11% +$258K 0.06% 206
2016
Q4 		$2.21M Sell
45,834
-3,756
-8% -$186K 0.05% 222
2016
Q3 		$2.67M Buy
49,590
+18,307
+59% +$1M 0.06% 191
2016
Q2 		$1.7M Buy
31,283
+693
+2% +$36.5K 0.04% 244
2016
Q1 		$1.55M Sell
30,590
-97
-0.3% -$4.83K 0.04% 259
2015
Q4 		$1.55M Buy
30,687
+3,372
+12% +$172K 0.04% 245
2015
Q3 		$1.31M Sell
27,315
-12,143
-31% -$632K 0.04% 238
2015
Q2 		$2.05M Sell
39,458
-3,244
-8% -$183K 0.05% 194
2015
Q1 		$2.46M Buy
42,702
+4,108
+11% +$236K 0.07% 185
2014
Q4 		$2.06M Buy
38,594
+6,815
+21% +$381K 0.06% 179
2014
Q3 		$1.83M Buy
31,779
+1,052
+3% +$64.5K 0.05% 186
2014
Q2 		$2.05M Buy
30,727
+1,298
+4% +$87.9K 0.06% 186
2014
Q1 		$1.97M Buy
29,429
+1,358
+5% +$91.8K 0.06% 189
2013
Q4 		$1.87M Buy
28,071
+71
+0.3% +$4.6K 0.06% 194
2013
Q3 		$1.76M Buy
28,000
+1,472
+6% +$94.8K 0.06% 191
2013
Q2 		$1.66M Buy
+26,528
New +$1.68M 0.06% 183

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

HL Financial Services's GSK Position: Q1 2019 in Review

HL Financial Services reduced its GSK (GSK) stake by 2.6% in Q1 2019, selling an estimated $50.5K and leaving 37,834 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #289.

HL Financial Services first reported a position in GSK in Q2 2013 and has held it in 24 quarters since. The position peaked at $2.68M in Q1 2017. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

  • HL Financial Services held 37,834 shares of GSK worth $1.98M as of Q1 2019.
  • HL Financial Services sold 1,010 GSK shares in Q1 2019, an estimated $50.5K.
  • GSK made up 0.03% of HL Financial Services's portfolio in Q1 2019, its #289 holding.
  • HL Financial Services first reported a position in GSK in Q2 2013 and has held it in 24 quarters since.
  • HL Financial Services's GSK position peaked at $2.68M in Q1 2017.
  • 847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.